1183104-54-2

Usage

Chemical compound

2-amino-2-[3-(trifluoromethyl)phenyl]propanamide

Molecular weight

219.2 g/mol

Upstream product

• 953741-94-1 2-amino-2-[3-(trifluoromethyl)phenyl]propionitrile 
• 349-76-8 3'-(trifluoromethyl)acetophenone 

Downstream Products

• 1245940-52-6 tert-Butyl {1-amino-1-oxo-2-[3-(trifluoromethyl)phenyl]propan-2-yl}carbamate 
• 1245940-99-1 2-({[3-(4-Chlorophenyl)-4-(2-fluorobenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]acetyl}amino)-2-[3-(trifluoromethyl)phenyl]propanamide 
• 1245940-53-7 tert-butyl {(2R)-1-amino-1-oxo-2-[3-(trifluoromethyl)phenyl]propan-2-yl}carbamate 
• 1245940-54-8 tert-butyl {(2S)-1-amino-1-oxo-2-[3-(trifluoromethyl)phenyl]propan-2-yl}carbamate 
• 1245940-56-0 (2S)-2-Amino-2-[3-(trifluoromethyl)phenyl]propanamide hydrochloride 
• 1245940-75-3 (2S)-2-[({3-(4-Chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl}acetyl)amino]-2-[3-(trifluoromethyl)phenyl]propanamide 
• 1245940-78-6 (2S)-2-[({3-(4-Chlorophenyl)-5-oxo-4-[(2R)-3,3,3-trifluoro-2-hydroxypropyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl}acetyl)amino]-2-[3-(trifluoromethyl)phenyl]propanamide 
• 1245940-98-0 C₂₄H₂₁F₆N₅O₄ 
• 1245940-97-9 C₂₄H₂₁F₆N₅O₄ 
• 1245941-00-7 C₂₇H₂₂ClF₄N₅O₃ 
• 1245941-01-8 C₂₇H₂₂ClF₄N₅O₃ 
• 1245940-96-8 2-[({4-Cyclopropyl-5-oxo-3-[2-(trifluoromethoxy)phenyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl}acetyl)amino]-2-[3-(trifluoromethyl)phenyl]propanamide 

Relevant academic research and scientific papers

SUBSTITUTED N-PHENETHYLTRIAZOLONEACETAMIDES AND USE THEREOF

The present application relates to novel substituted N-phenethyltriazoloneacetamides, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medica

TRIAZOLE DERIVATIVES AS VASOPRESSIN-RECEPTOR INHIBITORS FOR TREATING CARDIAC INSUFFICIENCY

The present application relates to novel substituted phenylalanine derivatives, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.